NPA submits comments to Congressional Task Force on Economic Growth in Puerto Rico after ensuring the issue would be subject to task force review.
FDA today released an unprecedented Federal Register (FR) notice (Docket No: FDA-2016-N-2523) with major implications for acknowledged new dietary ingredient notifications.
NPA today responded to the United States Drug Enforcement Agency’s (DEA) decision to add kratom and mitragynine to its list of schedule I drugs.
NPA submitted a formal request to the Food and Drug Administration (FDA) for an extension of the comment period by 30 days regarding the opportunity for stakeholder comment on the newly released guidance re-draft for New Dietary Ingredient Notifications.
The updated requirements to make GRAS conclusions have widespread implications for the conventional food and dietary supplement industry.
The NPA Awards salute industry pioneers and leaders for their accomplishments in science, environmental issues, advocacy, social responsibility, and the industry at large.